Rita Jain

Insider Reports History

Location
Hampton, NJ
Signature
/s/ Eric Loumeau, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Rita Jain:

Company Role Class Num Shares Value Price $ Report Date Ownership
ANAPTYSBIO, INC Director Common Stock 11,864 $237,635 $20.03 15 Jun 2025 Direct
ANAPTYSBIO, INC Director Restricted Stock Unit 4,000 $92,259 $15.30 06 Jan 2026 Direct
Avalo Therapeutics, Inc. Director Stock Option (Right to Buy) 1,043 $15,373 $14.74 31 Dec 2025 Direct
SAB Biotherapeutics, Inc. Director Stock Option (right to buy) 240,000 05 Jan 2026 Direct
Celldex Therapeutics, Inc. Director Non-Qualified Stock Option (right to buy) 16,500 05 Jun 2025 Direct
Celldex Therapeutics, Inc. Director Non-Qualified Stock Option (right to buy) 16,500 13 Jun 2024 Direct
ANAPTYSBIO, INC Director Stock Option (right to buy) 5,500 06 Jan 2026 Direct
ChemoCentryx, Inc. EVP, Chief Medical Officer, Director Common Stock 0 $50.95 20 Oct 2022 Direct
ChemoCentryx, Inc. EVP, Chief Medical Officer, Director Restricted Stock Unit 0 20 Oct 2022 Direct
ChemoCentryx, Inc. EVP, Chief Medical Officer, Director Stock Option 0 20 Oct 2022 Direct
Provention Bio, Inc. Director Option to Purchase Common Stock 0 27 Apr 2023 Direct

Insider Reports Filed by Rita Jain

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ANAB ANAPTYSBIO, INC 06 Jan 2026 2 $0 4 Director 08 Jan 2026, 16:06
SABS SAB Biotherapeutics, Inc. 05 Jan 2026 1 $0 4 Director 07 Jan 2026, 16:41
SABS SAB Biotherapeutics, Inc. 05 Jan 2026 0 $0 3 Director 07 Jan 2026, 16:36
AVTX Avalo Therapeutics, Inc. 31 Dec 2025 1 +$15,374 4 Director 05 Jan 2026, 16:05
AVTX Avalo Therapeutics, Inc. 30 Sep 2025 1 $0 4 Director 02 Oct 2025, 16:11
AVTX Avalo Therapeutics, Inc. 17 Jun 2025 1 $0 4 Director 18 Jun 2025, 16:08
AVTX Avalo Therapeutics, Inc. 17 Jun 2025 0 $0 3 Director 18 Jun 2025, 16:00
ANAB ANAPTYSBIO, INC 15 Jun 2025 3 $0 4 Director 17 Jun 2025, 18:33
CLDX Celldex Therapeutics, Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 16:10
ANAB ANAPTYSBIO, INC 07 Jan 2025 2 $0 4 Director 07 Jan 2025, 17:30
ANAB ANAPTYSBIO, INC 15 Jun 2024 3 $0 4 Director 18 Jun 2024, 20:14
CLDX Celldex Therapeutics, Inc. 13 Jun 2024 1 $0 4 Director 17 Jun 2024, 16:11
ANAB ANAPTYSBIO, INC 03 Jan 2024 2 $0 4 Director 05 Jan 2024, 17:01
/report/000149315223013912-jain-rita-2023-04-27 Provention Bio, Inc. 27 Apr 2023 1 $0 4 Director 27 Apr 2023, 18:03
ANAB ANAPTYSBIO, INC 03 Apr 2023 4 $0 4 Director 06 Apr 2023, 17:05
ANAB ANAPTYSBIO, INC 03 Apr 2023 0 $0 3 Director 06 Apr 2023, 17:03
CLDX Celldex Therapeutics, Inc. 16 Feb 2023 1 $0 4 Director 21 Feb 2023, 15:30
CLDX Celldex Therapeutics, Inc. 16 Feb 2023 0 $0 3 Director 21 Feb 2023, 15:20
/report/000149315223000620-jain-rita-2023-01-03 Provention Bio, Inc. 03 Jan 2023 1 $0 4 Director 05 Jan 2023, 15:31
/report/000149315223000616-jain-rita-2023-01-03 Provention Bio, Inc. 03 Jan 2023 0 $0 3 Director 05 Jan 2023, 15:29
/report/000089924322034089-jain-rita-2022-10-20 ChemoCentryx, Inc. 20 Oct 2022 8 $0 4 EVP, Chief Medical Officer, Director 24 Oct 2022, 19:13
/report/000120919122031743-jain-rita-2022-05-20 ChemoCentryx, Inc. 20 May 2022 2 $0 4 EVP, Chief Medical Officer, Director 24 May 2022, 19:27
/report/000120919122021541-jain-rita-2022-03-27 ChemoCentryx, Inc. 27 Mar 2022 2 $0 4 EVP, Chief Medical Officer, Director 29 Mar 2022, 19:50
/report/000120919122012915-jain-rita-2022-02-22 ChemoCentryx, Inc. 22 Feb 2022 2 $0 4 EVP, Chief Medical Officer, Director 24 Feb 2022, 19:46
/report/000120919121060003-jain-rita-2021-10-05 ChemoCentryx, Inc. 05 Oct 2021 1 $0 4 EVP, Chief Medical Officer, Director 07 Oct 2021, 20:52
/report/000120919121035542-jain-rita-2021-05-20 ChemoCentryx, Inc. 20 May 2021 4 $0 4 Director 24 May 2021, 19:55